| pubmed-article:137557 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:137557 | lifeskim:mentions | umls-concept:C1257930 | lld:lifeskim |
| pubmed-article:137557 | lifeskim:mentions | umls-concept:C0597520 | lld:lifeskim |
| pubmed-article:137557 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:137557 | pubmed:dateCreated | 1977-2-26 | lld:pubmed |
| pubmed-article:137557 | pubmed:abstractText | The ability of human mammary tumors to convert 7alpha 3H-testerone to estrogens was examined in order to determine whether this bore any relationship to estrogen receptor and steroid sulfurylation levels; such levels being indicative of hormone dependency. In 8 out of 9 tumors, formation of estradiol-17beta from testosterone was demonstrated. Those tumors showing the lowest conversion of testosterone to estradiol-17beta possessed the highest levels of dehydroepiandrosterone sulfotransferase which lends support to data implicating sulfurylation in the regulation of steroid metabolism in human tumors. All tumors activated sulfate to adenosine-3'-phospho-5'-phosphosulfate and the concentrations were significantly correlated withe the recorded levels of dehydroepiandrosterone sulfate. Estrogen receptor levels did not show any obvious relationship to the other parameters. | lld:pubmed |
| pubmed-article:137557 | pubmed:language | eng | lld:pubmed |
| pubmed-article:137557 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:137557 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:137557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:137557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:137557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:137557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:137557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:137557 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:137557 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:137557 | pubmed:issn | 0039-128X | lld:pubmed |
| pubmed-article:137557 | pubmed:author | pubmed-author:LiKK | lld:pubmed |
| pubmed-article:137557 | pubmed:author | pubmed-author:McDonaldDD | lld:pubmed |
| pubmed-article:137557 | pubmed:author | pubmed-author:AdamsJ BJB | lld:pubmed |
| pubmed-article:137557 | pubmed:author | pubmed-author:ChandraD PDP | lld:pubmed |
| pubmed-article:137557 | pubmed:author | pubmed-author:InK LKL | lld:pubmed |
| pubmed-article:137557 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:137557 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:137557 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:137557 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:137557 | pubmed:pagination | 561-74 | lld:pubmed |
| pubmed-article:137557 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:137557 | pubmed:meshHeading | pubmed-meshheading:137557-H... | lld:pubmed |
| pubmed-article:137557 | pubmed:meshHeading | pubmed-meshheading:137557-T... | lld:pubmed |
| pubmed-article:137557 | pubmed:meshHeading | pubmed-meshheading:137557-B... | lld:pubmed |
| pubmed-article:137557 | pubmed:meshHeading | pubmed-meshheading:137557-E... | lld:pubmed |
| pubmed-article:137557 | pubmed:meshHeading | pubmed-meshheading:137557-F... | lld:pubmed |
| pubmed-article:137557 | pubmed:meshHeading | pubmed-meshheading:137557-D... | lld:pubmed |
| pubmed-article:137557 | pubmed:meshHeading | pubmed-meshheading:137557-S... | lld:pubmed |
| pubmed-article:137557 | pubmed:meshHeading | pubmed-meshheading:137557-R... | lld:pubmed |
| pubmed-article:137557 | pubmed:year | 1976 | lld:pubmed |
| pubmed-article:137557 | pubmed:articleTitle | Steroid metabolism by human mammary carcinoma. | lld:pubmed |
| pubmed-article:137557 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:137557 | lld:pubmed |
